I find it concerning that she is unable to admit any mistakes, no study is perfect and her first study in Science certainly had room for improvement.
I feel this is frankly an arrogant response to Singh's Study at this point; "This study says nothing", really?? Most scientist do not like or respect Dr. Mikovits because repeated statements like this.
Well, some people might find Judy's use of wording slightly jarring, but she is totally accurate when she says that this study tells us nothing, other than the fact that Singh was unable to detect XMRV (Disclaimer - I haven't read through all of the Singh study yet, but until I do I'm assuming that this is the case, as with all the other zero-zero studies.) I expect that Judy is probably severely frustrated and is purposely defending her research with unambiguous and clear language.
I don't agree that Judy should admit any mistakes, even if her first study had room for improvement, because her huge body of work is solid, and she has checked it, and rechecked it, using more and more detailed research as time goes by.
Judy has carried out an immense amount of unpublished work since the first Science study, which she probably completed about two years ago now.
Unfortunately no one will publish any of her work for purely political reasons, it appears, simply because her name is attached to it, not because of the quality of the work.
Singh's study failed to find XMRV and we must remember that absence of evidence is not the same of evidence of absence, however excellent Singh is as a scientist.
It is possible that we are witnessing science at its limits of knowledge here, and that scientists like Singh are relying on their existing knowledge, rather than being innovative.
I agree that XMRV is not looking good right now, but the case is not settled, and even Switzer from the CDC has now found XMRV in prostate cancer patients now, and is saying that it isn't lab contamination, or mouse contamination, or a virus originating from a cell line... He is saying that they have found brand new virus variants in prostate cancer patients, and has admitted that they are at the edge of their detection limits which is why they can't always detect the virus. This is big news, as far as I'm concerned, which seems to have gone unnoticed under the radar (
see here for news about this).
We have to wait for the Lipkin study results before we can make any definite conclusions about XMRV.
If Judy and Lo cannot successfully and reliably detect XMRV in that study, then XMRV will be as good as dead, and we will all have to admit that Judy and Lo cannot reliably replicate their own work. But until that time, XMRV is still very much alive, and kicking, in my opinion.